Trial Profile
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Cefpodoxime; Temozolomide; Vincristine
- Indications CNS cancer; Lymphoma; Solid tumours
- Focus Adverse reactions
- 28 Jul 2006 New trial record.